Perry Buffington – PESI – Psychopharmacology 2-Day Conference

Description

Perry Buffington – PESI – Psychopharmacology 2-Day Conference download, Perry Buffington – PESI – Psychopharmacology 2-Day Conference review, Perry Buffington – PESI – Psychopharmacology 2-Day Conference free

Perry Buffington – PESI – Psychopharmacology 2-Day Conference

• Learn current understanding of how & why mental health medications work
• Understand which medications are evidenced-based to best treat which disorders
• Improve your clients’ responses and clinical outcomes to medications
• Help your clients recognize side effects and learn how to manage them
• Learn about new trends in prescribing
• Understand current controversies in the field
• New and emerging ethical dilemmas both prescribing and non-prescribing clinicians face daily

Spend two action-packed days learning about the newest advances in psychopharmacology and contemporary trends in medication management. From his unique perspective, Dr. Perry Buffington teaches psychopharmacology thoughtfully, with an emphasis on the experience of the client. Dr. Buffington’s years of experience in mental health and passion for clients, shines through in the detail and thoroughness of his presentation.

Clients often only have a few minutes with their prescriber and require additional support. It’s vital that you are able to answer their questions, help manage side effects and understand reactions. Designed for counselors, nurses, psychotherapists, psychologists, and other mental health professionals, Dr. Buffington provides the information you need in order to best help your clients.

This conference allows time for exploration of underrepresented areas, including ADHD, substance use disorders and psychopharmacological ethics. Take home specialized guidelines for geriatrics, and clients with chronic pain. Discuss how the DSM-5® and the Affordable Healthcare Law have impacted prescribing patterns and the use of psychotropics in newly defined diagnoses. In addition to a general ‘nuts and bolts’ review of medications, you will examine case examples, discuss medication controversies and how to effectively collaborate with prescribing practitioners. You will find this conference to have the most up- to-date medication information and how to use it most effectively with your client.

Speaker

Perry W. Buffington, PhD, MS
Perry Buffington, Ph.D., M.S., has over 20 years of experience in the medical consulting field and is currently a full-time senior lecturer at the University of Georgia, teaching psychopharmacology at the undergraduate and graduate levels. He is former chairman of the prestigious Florida Psychological Association’s Prescriptive Authority Committee and teaches seminars nationwide on minimizing psychopharmacological errors.

As the author of eight books (currently working on his first psychopharmacology text), his by-line has appeared in hundreds of periodicals including the Saturday Evening Post, USA Today, and Success. He is the former contributing editor for Delta Air Lines’ in-flight magazine, Sky, and served as a syndicated newspaper/web columnist for Universal Press. Additional, he hosted his own radio show, syndicated nationally, by Envison Radio Networks.

Perry’s presentation style is engaging, a blend of education and entertainment; as a result, critics (and especially his students) applaud his ability to make complicated topics understandable and applicable – even useful!!

Speaker Disclosures:
Financial: Dr. Perry Buffington has an employment relationship with the University of Georgia, and he is the owner of GoBuff Enterprises. He receives a speaking honorarium and recording royalties from PESI, Inc. Dr. Buffington is a published author and receives royalties. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Perry Buffington is a member of the Florida Psychological Association.

Objectives

1. Analyze the historical antecedents of psychopharmacological products and their relation to today’s psychotropic medications.
2. Designate the mechanism of action of today’;s psychotropic medications and how it relates to your clients.
3. Breakdown the process of medication selection and receptor activation/blocking for specific disorders.
4. Communicate the side effects including nutritional, cognitive, sexual, and behavioral associated with psychotropic medications.
5. Specify how medications are chosen for mood disorders and specific patient characteristics.
6. Compile medication treatment options for your clients with ADHD.
7. Determine the unique medication considerations for geriatric clients.
8. Determine acute and chronic pain and methods of treatment.
9. Analyze future trends, including preventing side effects vs. managing side effects.
10. Establish ethical issues specifically relating to the child and adolescent population as it relates to clinical psychopharmacology.
11. Apply traditional standards (autonomy, beneficence, nonmaleficence, confidentiality, veracity) of ethical behavior to issues peculiar to the practice of clinical psychopharmacology.
12. Explore specific ethical issues and their resolve to the everyday practice of clinical psychopharmacology.

Outline

DAY ONE

PSYCHOPHARMACOLOGY

• Historical antecedents of modern psychopharmacology
• Diagnostic issues
• Clarification of terms
• Drug metabolism concepts: pharmacokinetics & pharmacodynamics
• Drug mechanism of action
• Placebo & Nocebo
• Pharmacotherapy vs. Pharmacotherapy
• Developing highly effective collaborations with prescribers

DEPRESSIVE DISORDERS

• Biogenic Amine, Cortisol, Down-Regulation, & Neurotropic Hypotheses
• Neurochemistry of depression
• Types of anti-depressants
• Preventing side effects
• Tardive Dysphoria: real or imagined?

ANXIETY DISORDERS & OBSESSIVE COMPULSIVE DISORDERS & TRAUMA RELATED DISORDERS

• Neurochemistry of anxiety
• GAD, panic disorders, phobias
• OCD
• PTSD
• Physiological interventions
• Anti-anxiety medications
• Anti-depressants
• Non-pharmacologic options
• Benzodiazepines: risks and benefits
• Preventing side effects

BIPOLAR DISORDERS

• Neurochemistry
• The Bipolar Spectrum & DSM-5® Changes
• Mood stabilizers
  • Lithium
  • Anti-convulsants & neuromodulators
• Typical, atypical, & third-generation antipsychotics
• Effective strategies for improving outcomes for clients

PSYCHOTIC DISORDERS/ SCHIZOPHRENIA

• Neurochemistry of psychosis and schizophrenia
• Antipsychotic Medications:
  • First generation (typical)
  • Second generation (atypical)
• Managing side effects
  • Extrapyramidal symptoms and TD
  • Metabolic problems- what blood tests are needed and when
  • Preventing Diabetes Mellitus
• Recognizing hyperprolactinemia- and why you need to know
• Use of atypical antipsychotics for multiple disorders

LIMITATIONS OF THE RESEARCH & POTENTIAL RISKS

DAY TWO

ATTENTIONAL DISORDERS

• Differential diagnosis
• Neurochemistry of ADHD
• Treatment controversies
• Substance abuse and ADHD
• Stimulant medications
• Non-stimulant options
• Preventing side effects

SUBSTANCE ABUSE DISORDERS

• Neurochemistry of addiction
• Negative reinforcement & creation of habits
• Alcohol
• Caffeine
• Nicotine
• Cannabis
• Opiates
• PCP & Ketamine
• MDMA (Ecstasy)
• Energy vs. Chill Drinks
• Over-the-counter & herbal psychopharmacology
• Addiction treatments
• Behavioral addictions

SPECIAL POPULATIONS

• Specialized guidelines for geriatric patients
• Dementia treatment
• Slow vs. rapid metabolizers (genetic polymorphisms)

TREATING CLIENTS PAIN

• Acute vs. chronic pain
• Alternatives to pharmacology
• Pain vs. depression: which comes first?

ETHICS & PSYCHOPHARMACOLOGY 

• High-risk pharmacology & psychopharmacology
• Off-label use of medications
• Prescribing for children
• Elective psychopharmacology
• Marketing of mental illness
• Polypharmacy
• Informed vs. uninformed consent
• Patient & third party pressures
• Professional boundaries
• Ethics associated with medical errors
• Role of placebo

FUTURE TRENDS

• Change of mind: preventing vs. managing side effects
• Medicalization of normal
• Computer assisted devices
• New meds, new diagnoses, new theories, new normal
• Top 10 Medical Emergencies
• Integrating psychotherapy with psychopharmacology

LIMITATIONS OF THE RESEARCH & POTENTIAL RISKS

Target Audience

Addiction Counselors, Case Managers, Counselors, Marriage & Family Therapists, Nurses, Pharmacists, Psychologists, Social Workers, and other Mental Health Professionals

Reviews

George S
“I was very satisfied with this course. I learned a great deal from this program. The presenter was excellent. I would take another course with this presenter. I will take another course with this company. You all have above average, superior CEU programs.”

Lisa G
“I was very en-captured with this seminar. To be honest I was a little unsure at first because I am a FNP and I didn’t know if I would be able to understand the content. I was proved wrong 1 Dr. Buff made this seminar very intersting and fun. He was right I was overwhelmed the first day and I thought my gosh I never learned any of this in FNP school. The second day I followed along and learned even more. I highly recommend this course!”

Frequently Asked Questions:

1. Innovative Business Model:
   • Embrace the reality of a genuine business! Our approach involves forming a group buy, where we collectively share the costs among members. Using these funds, we purchase sought-after courses from sale pages and make them accessible to individuals facing financial constraints. Despite potential reservations from the authors, our customers appreciate the affordability and accessibility we provide.
2. The Legal Landscape: Yes and No:
   • The legality of our operations falls into a gray area. While we lack explicit approval from the course authors for resale, there’s a technicality at play. When procuring the course, the author didn’t specify any restrictions on resale. This legal nuance presents both an opportunity for us and a boon for those seeking budget-friendly access.
3. Quality Assurance: Unveiling the Real Deal:
   • Delving into the heart of the matter – quality. Acquiring the course directly from the sale page ensures that all documents and materials are identical to those obtained through conventional means. However, our differentiator lies in going beyond personal study; we take an extra step by reselling. It’s important to note that we are not the official course providers, meaning certain premium services aren’t included in our package:
     • No coaching calls or scheduled sessions with the author.
     • No access to the author’s private Facebook group or web portal.
     • No entry to the author’s exclusive membership forum.
     • No direct email support from the author or their team.

   We operate independently, aiming to bridge the affordability gap without the additional services offered by official course channels. Your understanding of our unique approach is greatly appreciated.

Refund is acceptable:

• Firstly, item is not as explained
• Secondly, Item do not work the way it should.
• Thirdly, and most importantly, support extension can not be used.

Thank you for choosing us! We’re so happy that you feel comfortable enough with us to forward your business here.